NCT00541697View on ClinicalTrials.gov

Eze/Simva Switch Study in Diabetics (0653A-807)

PHASE3CompletedINTERVENTIONAL
Enrollment

648

Participants

Timeline

Start Date

January 19, 2005

Primary Completion Date

September 28, 2005

Study Completion Date

October 14, 2005

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

MK0653A, ezetimibe (+) simvastatin / Duration of Treatment: 6 Weeks

DRUG

Comparator: atorvastatin / Duration of Treatment: 6 Weeks

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00541697 - Eze/Simva Switch Study in Diabetics (0653A-807) | Biotech Hunter | Biotech Hunter